|Day Low/High||29.18 / 29.34|
|52 Wk Low/High||20.45 / 30.80|
Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of NxStage Medical, Inc.
DJIA, S&P 500 and Nasdaq all rise slightly on the session.
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased NxStage Medical, Inc.
The Dow has closed with a record for eight straight days. It's going for its ninth.
There's no advantage in trying to predict the next move right now.
The Dow could close with its ninth day of records.
Fresenius Medical Care, the world's largest provider of dialysis products and services, has signed an agreement to acquire NxStage Medical, Inc.
Investors in NxStage Medical Inc saw new options become available this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NXTM options chain for the new August 18th contracts and identified one put and one call contract of particular interest.
Data presentations to be showcased at the 54th ERA-EDTA Congress
In trading on Tuesday, shares of NxStage Medical Inc crossed below their 200 day moving average of $25.67, changing hands as low as $20.45 per share. NxStage Medical Inc shares are currently trading off about 15.6% on the day.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in NxStage Medical Inc , where a total of 2,114 contracts have traded so far, representing approximately 211,400 underlying shares. That amounts to about 55.1% of NXTM's average daily trading volume over the past month of 383,800 shares.
On-site hemodialysis with NxStage System One provides cost-effective alternative to expensive transportation services associated with off-site dialysis